» Articles » PMID: 35510348

Potential Inhibitors of SARS-CoV-2 from (Sabine) Prance Ex F. White: Chemoinformatic and Molecular Modeling Studies for Three Key Targets

Overview
Specialty Pharmacology
Date 2022 May 5
PMID 35510348
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: The novel coronavirus disease-2019 (COVID-19) that emerged in China, is a highly transmittable and pathogenic viral infection caused by the severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2); the disease has been declared by the World Health Organization as a Public Health Emergency of International Concern. The unavailability of approved therapeutic agents or vaccines is of great concern. This study performed molecular docking and absorption, distribution, metabolism, excretion and toxicity (ADMET) analysis of some compounds isolated from (Sabine) Prance ex F. White (Chrysobalanaceae) against three targets of SARS-CoV-2 proteins (3C-like protease, spike protein, and papain-like protease).

Materials And Methods: Phytoconstituents isolated from were screened against key targets of SARS-CoV-2 using Auto Dock Vina, while the ADMET analysis was performed using swiss ADME and pkCSM ADMET descriptors algorithm protocols.

Results: The computational studies revealed that the compounds (catechin, catechin-3-rhamnoside, quercetin, and epicatechin) isolated from can effectively bind with high affinity and lower energy values to the three target proteins of SARS-CoV-2. ADMET analysis was used to predict important pharmacokinetic properties of the compounds, such as aqueous solubility, blood-brain barrier, plasma protein binding, CYP2D6 binding, intestinal absorption, and hepatotoxicity.

Conclusion: The findings of this study have shown that contains potential leads for SARS-CoV-2 inhibition and thus, should be studied further for development as therapeutic agents against COVID-19.

Citing Articles

A Flavonoid-Rich Extract of L. Reduced Lipid Peroxidation in a Rat Experimental Model of Gentamicin Nephrotoxicity.

Ungur R, Borda I, Codea R, Ciortea V, Nasui B, Muste S Materials (Basel). 2022; 15(3).

PMID: 35160718 PMC: 8837157. DOI: 10.3390/ma15030772.

References
1.
Hussain A, Kaler J, Tabrez E, Tabrez S, Tabrez S . Novel COVID-19: A Comprehensive Review of Transmission, Manifestation, and Pathogenesis. Cureus. 2020; 12(5):e8184. PMC: 7301445. DOI: 10.7759/cureus.8184. View

2.
Lupia T, Scabini S, Mornese Pinna S, Di Perri G, De Rosa F, Corcione S . 2019 novel coronavirus (2019-nCoV) outbreak: A new challenge. J Glob Antimicrob Resist. 2020; 21:22-27. PMC: 7102618. DOI: 10.1016/j.jgar.2020.02.021. View

3.
Daina A, Michielin O, Zoete V . SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep. 2017; 7:42717. PMC: 5335600. DOI: 10.1038/srep42717. View

4.
Gurung A, Ali M, Lee J, Farah M, Al-Anazi K . Unravelling lead antiviral phytochemicals for the inhibition of SARS-CoV-2 M enzyme through in silico approach. Life Sci. 2020; 255:117831. PMC: 7243810. DOI: 10.1016/j.lfs.2020.117831. View

5.
Trott O, Olson A . AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2009; 31(2):455-61. PMC: 3041641. DOI: 10.1002/jcc.21334. View